705 followers
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer. https://t.co/hsKarY7v7j
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer. https://t.co/hsKarY7v7j
New study in @BMC_series: Authors @Research_Purdue used FLIM-FRET to screen #chromatin biomarkers in ER+ breast #cancer, uncovering novel drug targets for combination therapy. #epigenetics https://t.co/aDmh84YDSq
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer. https://t.co/VleQWTNVQv
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer. https://t.co/sPIS4JDow4 https://t.co/4ANqHeHlS2